These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3672727

  • 1. [Surgical treatment of diffuse toxic goiter associated with autoimmune thyroiditis].
    Tsarikovskaia NG, Tkach FS, Gorbenko VN.
    Vestn Khir Im I I Grek; 1987 May; 138(5):13-6. PubMed ID: 3672727
    [Abstract] [Full Text] [Related]

  • 2. [Surgical treatment of postoperative recurrences of thyrotoxicosis associated with autoimmune thyroiditis].
    Karachentsev IuI.
    Klin Khir (1962); 1989 May; (12):33-5. PubMed ID: 2632947
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Total thyroidectomy in the treatment of multinodular toxic goiter].
    De Toma G, Tedesco M, Gabriele R, Campli M, Plocco M, Borghese M, Letizia C.
    G Chir; 1995 May; 16(8-9):373-6. PubMed ID: 8645544
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The clinical validation of the indications for surgical treatment in thyroid diseases].
    Romanchishen AF.
    Vestn Khir Im I I Grek; 1994 May; 152(1-2):3-6. PubMed ID: 7701735
    [Abstract] [Full Text] [Related]

  • 7. [Surgical treatment of toxic goiter in diabetes mellitus patients].
    Myshkin KI, Bluvshteĭn GA, Korzhenevich VI, Nemirovskaia TIa.
    Vestn Khir Im I I Grek; 1984 Feb; 132(2):19-21. PubMed ID: 6372208
    [Abstract] [Full Text] [Related]

  • 8. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
    Zwirska-Korczala K, Berdowska A, Jochem J, Sitkiewicz A, Birkner E, Polaniak R, Jedrzejowska-Szypułka H, Korzonek-Szlacheta I.
    J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
    [Abstract] [Full Text] [Related]

  • 9. [Remote results of the surgical treatment of patients with diffuse toxic goiter depending on the immunologic status].
    Deĭkalo IN, Gerasimenko AA, Epishin AV.
    Vestn Khir Im I I Grek; 1985 Feb; 134(2):11-5. PubMed ID: 3873741
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Surgical treatment of recurrent forms of diffuse toxic goiter].
    Tsarikovskaia NG, Lutsenko GS, Tkach FS, Marinenko VA.
    Vestn Khir Im I I Grek; 1974 Apr; 112(4):3-6. PubMed ID: 4480324
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Changes in various indicators of the immune system in patients with diffuse toxic goiter after surgical treatment].
    Nugmanova LB, Ismailov SI.
    Vestn Khir Im I I Grek; 1988 May; 140(5):55. PubMed ID: 3264640
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Method of determining autoantibodies to thyroid antigens in diffuse toxic goiter and Hashimoto's thyroiditis].
    Aleksandrova GF, Vnotchenko SL, Konnova EV, Iur'eva NP.
    Sov Med; 1981 May; (5):36-9. PubMed ID: 7022680
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.